NCT00721006View on ClinicalTrials.gov

Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

September 30, 2010

Conditions
Critical Limb IschemiaSevere Leg IschemiaPeripheral Artery DiseasePeripheral Vascular Disease
Interventions
BIOLOGICAL

MESENDO

40 subcutaneous injections of biological product

BIOLOGICAL

Placebo

40 subcutaneous injections of placebo

Trial Locations (1)

70433

TCA Cellular Therapy, Covington

Sponsors
All Listed Sponsors
lead

TCA Cellular Therapy

INDUSTRY